Completed
Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma
NCT00225212
- Conditions
- Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States